| scholarly article | Q13442814 |
| P2093 | author name string | Pei Wang | |
| Rujun Gong | |||
| Zhangsuo Liu | |||
| Yan Ge | |||
| Lance Dworkin | |||
| Minglei Lu | |||
| Andrew Brem | |||
| P2860 | cites work | Practical uses for ecdysteroids in mammals including humans: an update | Q24806380 |
| FSGS: Diagnosis and Diagnostic Work-Up | Q26744558 | ||
| Secondary Focal Segmental Glomerulosclerosis: From Podocyte Injury to Glomerulosclerosis | Q26752830 | ||
| Testosterone and blood pressure regulation | Q33322436 | ||
| Development of focal segmental glomerulosclerosis after anabolic steroid abuse | Q33562274 | ||
| DRAR-CPI: a server for identifying drug repositioning potential and adverse drug reactions via the chemical-protein interactome | Q33894409 | ||
| Glomerular hypertension, abnormal glomerular growth, and progression of renal diseases | Q33928107 | ||
| Adverse effects of anabolic steroids in athletes. A constant threat | Q33988494 | ||
| Aldosterone as a mediator of progressive renal disease: pathogenetic and clinical implications | Q34198408 | ||
| Glycogen synthase kinase 3β dictates podocyte motility and focal adhesion turnover by modulating paxillin activity: implications for the protective effect of low-dose lithium in podocytopathy | Q34302891 | ||
| Effects and applications of arthropod steroid hormones (ecdysteroids) in mammals | Q34653015 | ||
| The Janus effect: two faces of aldosterone | Q34657857 | ||
| Chronic nephropathies of cocaine and heroin abuse: a critical review | Q34663316 | ||
| Therapeutic targeting of GSK3β enhances the Nrf2 antioxidant response and confers hepatic cytoprotection in hepatitis C. | Q34678974 | ||
| Chronic Kidney Disease. | Q51043966 | ||
| Pharmacological studies of insect metamorphosing hormone: ponasterone A, ecdysterone, and inokosterone, in the rat | Q52494177 | ||
| Podocyte Growing Pains in Adaptive FSGS. | Q53158267 | ||
| Overexpression of VEGF-A in podocytes of adult mice causes glomerular disease. | Q54682241 | ||
| Effect of gender on the progression of nondiabetic renal disease: a meta-analysis | Q73426433 | ||
| Role of androgens in mediating hypertension and renal injury | Q74581364 | ||
| Impact of androgen-induced oxidative stress on hypertension in male SHR | Q80258195 | ||
| High sirolimus levels may induce focal segmental glomerulosclerosis de novo | Q80797353 | ||
| Effects of testosterone on glomerular growth after uninephrectomy | Q95823204 | ||
| Aldosterone--a hormone of cardiovascular adaptation and maladaptation | Q36392694 | ||
| The renin-angiotensin system in glomerular podocytes: mediator of glomerulosclerosis and link to hypertensive nephropathy | Q36467553 | ||
| The podocyte's response to injury: role in proteinuria and glomerulosclerosis | Q36474870 | ||
| Sex differences and the role of sex steroids in renal injury | Q36497243 | ||
| Gender differences in the renin-angiotensin and nitric oxide systems: relevance in the normal and diseased kidney. | Q36724537 | ||
| The β isoform of GSK3 mediates podocyte autonomous injury in proteinuric glomerulopathy | Q36803722 | ||
| Phytoecdysteroids and anabolic-androgenic steroids--structure and effects on humans | Q37066139 | ||
| Gender and human chronic renal disease | Q37131828 | ||
| The Karlson Lecture. Phytoecdysteroids: what use are they? | Q37601390 | ||
| Aldosterone as a renal growth factor | Q37603628 | ||
| Aldosterone: effects on the kidney and cardiovascular system | Q37710377 | ||
| Mineralocorticoid receptor activation and blockade: an emerging paradigm in chronic kidney disease. | Q37853831 | ||
| Ecdysone signaling in adult Drosophila melanogaster | Q37981809 | ||
| Aldosterone blockade and the mineralocorticoid receptor in the management of chronic kidney disease: current concepts and emerging treatment paradigms | Q37984206 | ||
| Proteinuria should be used as a surrogate in CKD. | Q37990717 | ||
| Obesity and kidney disease: potential mechanisms | Q38078543 | ||
| Gender and the prevalence and progression of renal disease | Q38131616 | ||
| Aldosterone and the kidney: a rapidly moving frontier (an update). | Q38160215 | ||
| Discovery of resveratrol derivatives as novel LSD1 inhibitors: Design, synthesis and their biological evaluation | Q38728875 | ||
| PharmMapper 2017 update: a web server for potential drug target identification with a comprehensive target pharmacophore database | Q38804026 | ||
| Focal Segmental Glomerulosclerosis | Q38938623 | ||
| Estrogen receptor beta is involved in skeletal muscle hypertrophy induced by the phytoecdysteroid ecdysterone | Q38979970 | ||
| Androgens induce oxidative stress and radiation resistance in prostate cancer cells though NADPH oxidase. | Q39477655 | ||
| Ecdysteroids elicit a rapid Ca2+ flux leading to Akt activation and increased protein synthesis in skeletal muscle cells | Q39719269 | ||
| Increased body mass index is a risk factor for end-stage renal disease in the Chinese Singapore population | Q40192525 | ||
| Ecdysteroids: A novel class of anabolic agents? | Q41282434 | ||
| Nephron mass as a risk factor for progression of renal disease | Q41667489 | ||
| A new method for large scale isolation of kidney glomeruli from mice | Q42047954 | ||
| Genetic and Pharmacologic Targeting of Glycogen Synthase Kinase 3β Reinforces the Nrf2 Antioxidant Defense against Podocytopathy | Q42141815 | ||
| Direct fibrogenic effects of aldosterone on normotensive kidney: an effect modified by 11β-HSD activity | Q43143831 | ||
| Collapsing focal segmental glomerulosclerosis following treatment with high-dose pamidronate. | Q43617519 | ||
| Abolition of hypertension-induced end-organ damage by androgen receptor blockade in transgenic rats harboring the mouse ren-2 gene | Q44191986 | ||
| Anabolic activity of phytoecdysone-ecdysterone isolated from Rhaponticum carthamoides (Willd.) Iljin | Q44973757 | ||
| A spectrum of morphologic lesions of focal segmental glomerulosclerosis by Columbia criteria in human immunodeficiency virus infection | Q45359194 | ||
| The aggravating mechanisms of aldosterone on kidney fibrosis | Q46542770 | ||
| Body mass index and risk for end-stage renal disease | Q46876497 | ||
| The progression of chronic kidney disease: a 10-year population-based study of the effects of gender and age. | Q46891097 | ||
| FSGS as an Adaptive Response to Growth-Induced Podocyte Stress | Q47760613 | ||
| Glomerular hyperfiltration: definitions, mechanisms and clinical implications | Q48257561 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | ecdysteroid | Q138983 |
| P304 | page(s) | 12225 | |
| P577 | publication date | 2018-08-15 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | Activation of mineralocorticoid receptor by ecdysone, an adaptogenic and anabolic ecdysteroid, promotes glomerular injury and proteinuria involving overactive GSK3β pathway signaling | |
| P478 | volume | 8 |
| Q90347754 | Mineralocorticoid receptor: A hidden culprit for hemodialysis vascular access dysfunction | cites work | P2860 |
Search more.